191 related articles for article (PubMed ID: 20008098)
1. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma.
Uddin S; Bavi P; Siraj AK; Ahmed M; Al-Rasheed M; Hussain AR; Ahmed M; Amin T; Alzahrani A; Al-Dayel F; Abubaker J; Bu R; Al-Kuraya KS
Endocr Relat Cancer; 2010 Mar; 17(1):191-202. PubMed ID: 20008098
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.
Uddin S; Bu R; Ahmed M; Abubaker J; Al-Dayel F; Bavi P; Al-Kuraya KS
Mol Cancer; 2009 Sep; 8():74. PubMed ID: 19765303
[TBL] [Abstract][Full Text] [Related]
3. Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma.
Uddin S; Bu R; Ahmed M; Hussain AR; Ajarim D; Al-Dayel F; Bavi P; Al-kuraya KS
Leuk Lymphoma; 2010 Jul; 51(7):1305-14. PubMed ID: 20443680
[TBL] [Abstract][Full Text] [Related]
4. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
Fan YL; Li XQ
Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
[TBL] [Abstract][Full Text] [Related]
5. Role of X-Linked Inhibitor of Apoptosis as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Hussain AR; Bu R; Ahmed M; Jehan Z; Beg S; Al-Sobhi S; Al-Dayel F; Siraj AK; Uddin S; Al-Kuraya KS
J Clin Endocrinol Metab; 2015 Jul; 100(7):E974-85. PubMed ID: 25974735
[TBL] [Abstract][Full Text] [Related]
6. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
[TBL] [Abstract][Full Text] [Related]
7. Silencing of Long Non-coding RNA ENST00000606790.1 Inhibits the Malignant Behaviors of Papillary Thyroid Carcinoma through the PI3K/AKT Pathway.
Zuo Z; Liu L; Song B; Tan J; Ding D; Lu Y
Endocr Res; 2021 Feb; 46(1):1-9. PubMed ID: 32791924
[TBL] [Abstract][Full Text] [Related]
8. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
12. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
[TBL] [Abstract][Full Text] [Related]
13. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways.
Cheng SP; Yin PH; Hsu YC; Chang YC; Huang SY; Lee JJ; Chi CW
Oncol Rep; 2011 Nov; 26(5):1265-71. PubMed ID: 21750869
[TBL] [Abstract][Full Text] [Related]
14. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway.
Wang D; Chen J; Chen H; Duan Z; Xu Q; Wei M; Wang L; Zhong M
J Biosci; 2012 Mar; 37(1):91-101. PubMed ID: 22357207
[TBL] [Abstract][Full Text] [Related]
15. Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.
Degl'Innocenti D; Alberti C; Castellano G; Greco A; Miranda C; Pierotti MA; Seregni E; Borrello MG; Canevari S; Tomassetti A
PLoS One; 2010 Sep; 5(9):e12701. PubMed ID: 20877637
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
17. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
[TBL] [Abstract][Full Text] [Related]
19. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y
Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
